Replies to post #123422 on Anavex Life Sciences Corp (AVXL)

[Reyeton]

It would be interesting, if not enlightening, to see the language in the AVXL/BIIB agreement. There seems to be some arm twisting going on, possibly by BIIB. Dr Missling is no neophyte. I fully trust Dr Missling is the ultimate
warrior and will not bow to anyone, IMO. He knows what we have and is on a mission to bring it all to fruition. BIBB's deep pockets may get them into the headlines. I am fully confident that under Dr Missling's leadership, millions will benefit from the measured approach to bring our drugs to market, that Dr Missling is taking. Patience and Perspective is, at times, a tall order for this investor but I have to think of the unimaginable load those suffering from ALS, AD, Rett Syndrome, PD, etc. are carrying. We can't mess this up. God Bless Dr Missling.

[PeterKarol]

Ultimately FDA classification is what matters. If they think that models used by AVXL in this "general" epilepsy are of different etiology than let's say Rett then things are settled on those as two separate to be approved.